[治疗中的非肿瘤坏死因子生物制剂] - Suppr

Suppr

超能文献

[Non-TNF biologicals in therapy].

作者信息

Wollenhaupt Jürgen, Burmester Gerd-R

机构信息

Abteilung Rheumatologie und klinische Immunologie, Schön-Klinik Hamburg-Eilbeck, 22081 Hamburg, Deutschland.

出版信息

Z Rheumatol. 2010 Sep;69(7):579-80. doi: 10.1007/s00393-009-0527-2.

DOI:10.1007/s00393-009-0527-2

PMID:20703491

Abstract

摘要

相似文献

[Non-TNF biologicals in therapy].

Z Rheumatol. 2010 Sep;69(7):579-80. doi: 10.1007/s00393-009-0527-2.

Introduction to special section: biologic agents in the treatment of rheumatic diseases-the first decade.

Arthritis Rheum. 2009 May 15;61(5):559. doi: 10.1002/art.24578.

Rheumatoid vasculitis treated with infliximab.

J Rheumatol. 2005 Aug;32(8):1607-9.

Anti-tumour necrosis factor agents and lipid profile: a class effect?

Ann Rheum Dis. 2008 Jun;67(6):895-6. doi: 10.1136/ard.2007.078287.

[Rheumatoid arthritis: early aggressive therapy including biologicals -- pro].

Dtsch Med Wochenschr. 2005 Aug 19;130(33):1900. doi: 10.1055/s-2005-871917.

Tumor necrosis factor-alpha blocker induced tuberculosis.

J Rheumatol. 2010 Jul;37(7):1542; author reply 1543. doi: 10.3899/jrheum.100058.

[Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?].

Dtsch Med Wochenschr. 2007 Sep;132(37):1901-4. doi: 10.1055/s-2007-985615.

[Proteins in rheumatology and clinical immunology].

Ther Umsch. 2011 Nov;68(11):603-9. doi: 10.1024/0040-5930/a000220.

[TNF-alpha antagonists in therapy of rheumatoid arthritis].

Z Rheumatol. 2003 Jun;62(3):217.

Neurological complications of infliximab.

J Rheumatol. 2007 Jan;34(1):237; author reply 237-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Non-TNF biologicals in therapy].

Z Rheumatol. 2010 Sep;69(7):579-80. doi: 10.1007/s00393-009-0527-2.

Introduction to special section: biologic agents in the treatment of rheumatic diseases-the first decade.

Arthritis Rheum. 2009 May 15;61(5):559. doi: 10.1002/art.24578.

Rheumatoid vasculitis treated with infliximab.

J Rheumatol. 2005 Aug;32(8):1607-9.

Anti-tumour necrosis factor agents and lipid profile: a class effect?

Ann Rheum Dis. 2008 Jun;67(6):895-6. doi: 10.1136/ard.2007.078287.

[Rheumatoid arthritis: early aggressive therapy including biologicals -- pro].

Dtsch Med Wochenschr. 2005 Aug 19;130(33):1900. doi: 10.1055/s-2005-871917.

Tumor necrosis factor-alpha blocker induced tuberculosis.

J Rheumatol. 2010 Jul;37(7):1542; author reply 1543. doi: 10.3899/jrheum.100058.

[Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?].

Dtsch Med Wochenschr. 2007 Sep;132(37):1901-4. doi: 10.1055/s-2007-985615.

[Proteins in rheumatology and clinical immunology].

Ther Umsch. 2011 Nov;68(11):603-9. doi: 10.1024/0040-5930/a000220.

[TNF-alpha antagonists in therapy of rheumatoid arthritis].

Z Rheumatol. 2003 Jun;62(3):217.

Neurological complications of infliximab.

J Rheumatol. 2007 Jan;34(1):237; author reply 237-8.